NEURO CONSULT — r20260913s-6SERIES: THIS MONTH IN NEUROLOGYTHE EPILEPTOLOGIST
STAT

They just approved the first drug that fixes the actual cause of narcolepsy. The most common side effect is insomnia. We didn't cure it. We overshot it. Send this to the sleep doc who has been waiting twenty years for this.

EXPLAINED (ACCURACY-CHECKED)

The FDA approved oveporexton (ORZEYFUL) on Aug 5, 2026 — the first oral orexin receptor 2 agonist — for narcolepsy type 1, targeting the underlying orexin signaling deficit. The most common adverse events in the pivotal trials were insomnia and urinary urgency/frequency.

Verified: Takeda newsroom, NeurologyLive, Psychiatric Times, Drugs.com — oveporexton approved 2026-08-05 for NT1; most common AEs were insomnia and urinary urgency/frequency.
Reprint anywhere, non-commercially, with attribution to cerebrospinalectomy.com. We punch at specialties, the system, and ourselves — never at patients.
THE NEWSLETTER

Grand Rounds, but funny.

One joke, one accurate fact, one thing to send to your co-resident. Free. No sponsor gets your address.

JOIN THE NEWSLETTER
FREE·EVERY FRIDAY